Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. North American region is the largest blood cancer drugs market, due to the presence of
advanced diagnostic facilities and numerous blood cancer patients in USA. Presence of good healthcare
facilities for cancer related treatments and affordability among public owing to the favorable reimbursement
and insurance policies drive the growth of the North American blood cancer drugs market. Moreover, the
presence of major Pharmaceutical companies in the region and their huge investments in research and
development of blood cancer drugs is yielding new effective blood cancer drugs in the region. The increasing
awareness and preference for immunotherapy due to efficiency is expected to drive the North American
blood cancer market during the forecast period. Presence of large geriatric population and good healthcare
facilities for cancer treatments drive the European blood cancer drugs market. Due high rate of diagnosis of
blood cancer at initial stages and awareness about treatments among patients, the demand for the blood
cancer drugs is high in Europe and it drives the growth of the market. The expiry of patents of major blood
cancer drugs is expected to drive the growth of manufacturing of generic blood cancer drugs in near future.
Moreover, Europe has the policy to promote biologics and biosimilar drugs as an alternative for
chemotherapeutic drugs and it is expected to drive the European blood cancer drugs market. The initiatives
of major pharmaceutical companies to expand the operations in Presence of huge population, increasing
awareness about the blood cancer, investments by governments to improved healthcare facilities for cancer
treatments and promotion of alternative therapies such as immunotherapy and biologics are expected to
drive the growth of the Asia-Pacific blood cancer market. Low cost generic and biosimilar drugs for blood
cancer are expected to generate more demand in the Asia-Pacific blood cancer drugs market during the
forecast period.
Infinium Global Research